Functional and genetic aberrations of in vitro-cultured marrow-derived mesenchymal stromal cells of patients with classical Philadelphia-negative myeloproliferative neoplasms

Leukemia

Volumn 28, Issue 8, 2014, Pages 1742-1745

  Avanzini, M A ^a   Bernardo, M E ^b   Novara, F ^b   Mantelli, M ^a   Poletto, V ^a   Villani, L ^a   Lenta, E ^a   Ingo, D M ^a   Achille, V ^a   Bonetti, E ^a   Massa, M ^a   Campanelli, R ^a   Fois, G ^a   Catarsi, P ^a   Gale, R P ^c   Moretta, A ^a   Aronica, A ^a   Maccario, R ^a   Acquafredda, G ^a   Lisini, D ^d   Zecca, M ^a   Zuffardi, O ^b   Locatelli, F ^b   Barosi, G ^a   Rosti, V ^a   more..

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; DNA; ENDOGLIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; MICROSOMAL AMINOPEPTIDASE; THY 1 ANTIGEN;

CELL DIFFERENTIATION; CELL PROLIFERATION; CLASSICAL PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASM; DNA EXTRACTION; FUNCTIONAL DISEASE; GENE MUTATION; GENETIC DISORDER; HUMAN; IMMUNOPHENOTYPING; LETTER; MESENCHYMAL STROMA CELL; MYELOPROLIFERATIVE NEOPLASM; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PRIORITY JOURNAL; SENESCENCE;

BONE MARROW CELLS; CELLS, CULTURED; CHROMOSOME ABERRATIONS; HUMANS; MESENCHYMAL STROMAL CELLS; MYELOPROLIFERATIVE DISORDERS; PHILADELPHIA CHROMOSOME;

EID: 84905676442     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.97     Document Type: Letter

References (16)

1. Keating A. Mesenchymal stromal cells. Curr Opin Hematol 2006; 13: 419-425.
2. Lopez-Villar O, Garcia JL, Sanchez-Guijo FM, Robledo C, Vilaron EM, Hernandez-Campo P et al. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q-syndrome. Leukemia 2009; 23: 664-672.
3. Blau O, Baldus CD, Hofmann WK, Thiel G, Nolte F, Burmeister T et al. Mesenchymal stroma cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts. Blood 2011; 118: 5583-5592.
4. Geyh S, Oz S, Cadeddu RP, Fröbel J, Bruckner B, Kungden A et al. Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells. Leukemia 2013; 27: 1841-1851.
5. Raaijmakers MH, Mukherjee S, Guo S, Zhang S, Kobayashi T, Schoonmaker JA et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukemia. Nature 2010; 464: 852-857.
6. Pieri L, Guglielmelli P, Bogani C, Bosi A, Vannucchi AM. Mesenchymal stem cells from JAK2V617F mutant patients with primary myelofibrosis do not harbor JAK2 mutant allele. Leuk Res 2008; 32: 516-517.
7. Sakaguchi Y, Sekiya I, Yagishita K, Ichinose S, Shinomiya K, Muneta T. Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood 2004; 104: 2728-2735.
8. Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, Moretta A et al. Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007; 67: 9142-9149.
9. Lecourt S, Vanneaux V, Leblanc T, Leroux G, Ternaux B, Benbunan M et al. Bone marrow microenvironment in Fanconi anemia: a prospective functional study in a cohort of fanconi anemia patients. Stem Cell Dev 2010; 19: 203-208.
10. Tonon L, Bergamaschi G, Dellavecchia C, Rosti V, Lucotti C, Malabarba L et al. Unbalanced X-chromosome inactivation in haematopoietic cells from normal women. Br J Haematol 1998; 102: 996-1003.
11. Greenbaum A, Hsu YM, Day RB, Schuettpelz LG, Christopher MJ, Borgerding JN et al. CXCL12 in early mesenchymal progenitors is required for hematopoietic stem-cell maintenance. Nature 2013; 495: 227-230.
12. Flores-Figueroa E, Varma S, Montgomery K, Greenberg PL, Gratzinger D. Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodysplastic bone marrow. Lab Invest 2012; 92: 1330-1341.
13. Ben David U, Mayshar Y, Benvenisty N. Large scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human. Cell Stem Cell 2011; 9: 97-102.
14. Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1. J Natl Cancer Inst 2008; 100: 1519-1529.
15. Swierczek SI, Piterkova L, Jelinek J, Agarwal N, Hammoud S, Wilson A et al. Methylation of AR locus does not always reflect X chromosome inactivation state. Blood 2012; 119: e100-e109.
16. Erratum in: Blood 2012; 120: 4447. Cairns, Bradley [corrected to Cairns, Bradley RJ.